Avidity Sale Purchase Of Stock vs Begin Period Cash Flow Analysis

RNA Stock  USD 30.50  0.68  2.18%   
Avidity Biosciences financial indicator trend analysis is way more than just evaluating Avidity Biosciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avidity Biosciences is a good investment. Please check the relationship between Avidity Biosciences Sale Purchase Of Stock and its Begin Period Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.

Sale Purchase Of Stock vs Begin Period Cash Flow

JavaScript chart by amCharts 3.21.15201620182020202220241M10M100M10M100M1B
JavaScript chart by amCharts 3.21.15Sale Purchase Of Stocktotal: 76.3MBegin Period Cash Flowtotal: 1.7B

Sale Purchase Of Stock vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avidity Biosciences Sale Purchase Of Stock account and Begin Period Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.
Sale Purchase Of StockBegin Period Cash FlowDiversified AwaySale Purchase Of StockBegin Period Cash FlowDiversified Away100%
The correlation between Avidity Biosciences' Sale Purchase Of Stock and Begin Period Cash Flow is -0.18. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Avidity Biosciences, assuming nothing else is changed. The correlation between historical values of Avidity Biosciences' Sale Purchase Of Stock and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Avidity Biosciences are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Sale Purchase Of Stock i.e., Avidity Biosciences' Sale Purchase Of Stock and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.18
Relationship DirectionNegative 
Relationship StrengthInsignificant

Sale Purchase Of Stock

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from Avidity Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avidity Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.The current year's Selling General Administrative is expected to grow to about 65.4 M, whereas Issuance Of Capital Stock is forecasted to decline to about 221.3 M.
 2022 2023 2024 2025 (projected)
Research Development150.4M191.0M219.6M230.6M
Total Revenue9.2M9.6M8.6M6.4M

Avidity Biosciences fundamental ratios Correlations

0.940.940.99-0.260.870.76-0.08-0.710.950.62-0.64-0.80.94-0.050.990.95-0.74-0.940.960.860.95-0.850.86-0.86-0.25
0.940.890.95-0.240.750.70.13-0.650.870.49-0.44-0.720.940.160.930.92-0.66-0.890.920.740.89-0.720.8-0.72-0.33
0.940.890.9-0.30.90.51-0.2-0.630.990.72-0.61-0.680.920.120.920.93-0.47-0.970.930.720.84-0.70.88-0.71-0.14
0.990.950.9-0.260.850.8-0.03-0.680.920.5-0.58-0.770.94-0.040.990.94-0.77-0.910.940.820.95-0.810.81-0.82-0.37
-0.26-0.24-0.3-0.26-0.130.050.660.03-0.35-0.150.52-0.03-0.28-0.41-0.35-0.390.050.42-0.38-0.07-0.290.05-0.310.050.32
0.870.750.90.85-0.130.54-0.24-0.660.910.62-0.56-0.710.75-0.230.870.76-0.51-0.850.770.70.78-0.710.74-0.72-0.18
0.760.70.510.80.050.540.31-0.660.560.21-0.35-0.790.7-0.340.760.69-0.98-0.530.70.820.8-0.840.54-0.84-0.34
-0.080.13-0.2-0.030.66-0.240.31-0.24-0.27-0.290.62-0.220.06-0.04-0.12-0.09-0.270.25-0.080.07-0.03-0.07-0.16-0.060.0
-0.71-0.65-0.63-0.680.03-0.66-0.66-0.24-0.63-0.530.230.96-0.670.37-0.71-0.660.730.6-0.67-0.84-0.740.85-0.640.85-0.06
0.950.870.990.92-0.350.910.56-0.27-0.630.73-0.69-0.70.910.050.950.94-0.53-0.970.940.760.87-0.750.88-0.76-0.15
0.620.490.720.5-0.150.620.21-0.29-0.530.73-0.65-0.610.54-0.120.570.62-0.22-0.680.620.70.55-0.670.74-0.680.55
-0.64-0.44-0.61-0.580.52-0.56-0.350.620.23-0.69-0.650.36-0.510.09-0.64-0.630.350.6-0.63-0.55-0.530.55-0.530.560.0
-0.8-0.72-0.68-0.77-0.03-0.71-0.79-0.220.96-0.7-0.610.36-0.720.43-0.79-0.730.820.67-0.74-0.95-0.830.96-0.710.96-0.08
0.940.940.920.94-0.280.750.70.06-0.670.910.54-0.51-0.720.210.930.98-0.67-0.910.980.760.88-0.730.84-0.74-0.3
-0.050.160.12-0.04-0.41-0.23-0.34-0.040.370.05-0.120.090.430.21-0.040.170.39-0.160.14-0.35-0.060.440.130.44-0.25
0.990.930.920.99-0.350.870.76-0.12-0.710.950.57-0.64-0.790.93-0.040.96-0.75-0.940.960.830.95-0.830.84-0.84-0.32
0.950.920.930.94-0.390.760.69-0.09-0.660.940.62-0.63-0.730.980.170.96-0.67-0.941.00.790.9-0.770.87-0.77-0.25
-0.74-0.66-0.47-0.770.05-0.51-0.98-0.270.73-0.53-0.220.350.82-0.670.39-0.75-0.670.51-0.69-0.84-0.80.86-0.520.860.32
-0.94-0.89-0.97-0.910.42-0.85-0.530.250.6-0.97-0.680.60.67-0.91-0.16-0.94-0.940.51-0.94-0.73-0.890.7-0.920.710.19
0.960.920.930.94-0.380.770.7-0.08-0.670.940.62-0.63-0.740.980.140.961.0-0.69-0.940.810.91-0.780.87-0.79-0.24
0.860.740.720.82-0.070.70.820.07-0.840.760.7-0.55-0.950.76-0.350.830.79-0.84-0.730.810.89-0.990.81-0.990.1
0.950.890.840.95-0.290.780.8-0.03-0.740.870.55-0.53-0.830.88-0.060.950.9-0.8-0.890.910.89-0.870.91-0.87-0.25
-0.85-0.72-0.7-0.810.05-0.71-0.84-0.070.85-0.75-0.670.550.96-0.730.44-0.83-0.770.860.7-0.78-0.99-0.87-0.751.0-0.08
0.860.80.880.81-0.310.740.54-0.16-0.640.880.74-0.53-0.710.840.130.840.87-0.52-0.920.870.810.91-0.75-0.760.03
-0.86-0.72-0.71-0.820.05-0.72-0.84-0.060.85-0.76-0.680.560.96-0.740.44-0.84-0.770.860.71-0.79-0.99-0.871.0-0.76-0.08
-0.25-0.33-0.14-0.370.32-0.18-0.340.0-0.06-0.150.550.0-0.08-0.3-0.25-0.32-0.250.320.19-0.240.1-0.25-0.080.03-0.08
Click cells to compare fundamentals

Avidity Biosciences Account Relationship Matchups

Avidity Biosciences fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets333.9M427.6M638.8M628.6M722.8M759.0M
Other Current Liab10.9M28.0M60.9M39.9M45.8M48.1M
Total Current Liabilities14.6M29.7M51.9M80.7M92.8M97.4M
Total Stockholder Equity306.2M381.4M578.1M500.8M575.9M604.7M
Other Liab15.1M12.2M6.5M1.2M1.1M1.1M
Accounts Payable7.7M2.8M4.6M8.8M10.1M10.6M
Cash328.1M405.5M340.4M185.1M212.8M189.2M
Other Assets298K850K849K1.00.90.86
Other Current Assets3.5M5.6M8.3M14.9M17.1M17.9M
Total Liab27.7M46.2M60.7M127.8M147.0M154.3M
Common Stock4K5K7K8K7.2K6.8K
Property Plant Equipment631K1.9M15.6M15.0M17.3M18.1M
Short Long Term Debt Total938K10.0M10.7M9.9M11.3M8.6M
Net Tangible Assets(65.4M)306.2M381.4M578.1M664.8M698.0M
Property Plant And Equipment Net1.5M15.6M15.0M16.7M19.1M20.1M
Net Debt(327.2M)(395.6M)(329.7M)(175.2M)(157.7M)(165.6M)
Retained Earnings(66.5M)(184.5M)(358.5M)(570.8M)(513.7M)(488.0M)
Non Current Assets Total2.2M16.4M15.9M17.2M19.8M20.8M
Non Currrent Assets Other501K599K598K596K685.4K537.5K
Cash And Short Term Investments328.1M405.5M610.7M595.4M684.7M373.5M
Common Stock Shares Outstanding21.7M41.4M52.2M73.0M84.0M45.2M
Liabilities And Stockholders Equity333.9M427.6M638.8M628.6M722.8M390.4M
Non Current Liabilities Total13.1M16.5M8.8M47.1M42.4M37.1M
Capital Lease Obligations938K11.7M7.6M9.9M11.3M11.9M
Other Stockholder Equity38.9M566.2M939.3M1.1B1.2B1.3B
Net Invested Capital306.2M381.4M578.1M500.8M575.9M307.1M
Property Plant And Equipment Gross1.5M15.6M15.0M21.9M25.2M26.4M
Total Current Assets331.7M411.1M622.9M611.3M703.0M380.6M
Accumulated Other Comprehensive Income(5K)(187K)(2.7M)125K143.8K150.9K
Capital Stock4K5K7K8K7.2K6.8K
Net Working Capital317.1M381.5M571.0M530.6M610.2M345.5M
Short Term Debt7.7M3.5M6.2M14.8M17.1M17.9M
Current Deferred Revenue3.7M4.9M5.0M28.4M32.6M34.3M
Net Receivables1.2M900K2.1M1.1M1.3M1.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Avidity Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avidity Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avidity Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avidity Biosciences Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avidity Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Avidity Stock refer to our How to Trade Avidity Stock guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avidity Biosciences. If investors know Avidity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avidity Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.88)
Revenue Per Share
0.103
Quarterly Revenue Growth
(0.17)
Return On Assets
(0.18)
Return On Equity
(0.28)
The market value of Avidity Biosciences is measured differently than its book value, which is the value of Avidity that is recorded on the company's balance sheet. Investors also form their own opinion of Avidity Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Avidity Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avidity Biosciences' market value can be influenced by many factors that don't directly affect Avidity Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avidity Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avidity Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avidity Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

MDWD
Mediwound
17.99  -0.01  -0.06 
MEIP
MEI Pharma
2.68  0.13  5.10 
MDGL
Madrigal Pharmaceuticals
319.69  5.91  1.88 
MBRX
Moleculin Biotech
1.79  0.02  1.13 
MBIO
Mustang Bio
0.22  0.01  4.76 
EQ
Equillium
0.78  0.01  1.30 
MESO
Mesoblast
20.12  -0.49  -2.38 
MDXG
MiMedx Group
9.19  -0.09  -0.97 
MDCX
Medicus Pharma
2.51  0.08  3.29 
News Freq…Investor S…